Fig. 6: Analysis of thrombosis rate in PV using QRISK3 score.
From: QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
Thrombosis free survival (TFS) in patients with polycythaemia vera (PV) categorised based on QRISK3 score of either <5.5%, >5.5% and <7.5%, or ≥7.5%.
